Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Laminin Antikörper (AA 3013-3122)

LAMA2 Reaktivität: Human ELISA, WB, IHC (p) Wirt: Maus Monoclonal 2D4 unconjugated
Produktnummer ABIN7477801
  • Target Alle Laminin (LAMA2) Antikörper anzeigen
    Laminin (LAMA2) (Laminin, alpha 2 (LAMA2))
    Bindungsspezifität
    • 15
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 3013-3122
    Reaktivität
    • 26
    • 22
    • 17
    • 16
    • 15
    • 1
    • 1
    Human
    Wirt
    • 26
    • 1
    • 1
    Maus
    Klonalität
    • 26
    • 2
    Monoklonal
    Konjugat
    • 10
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Laminin Antikörper ist unkonjugiert
    Applikation
    • 13
    • 13
    • 11
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    ELISA, Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Verwendungszweck
    Mouse monoclonal antibody raised against a partial recombinant LAMA2.
    Sequenz
    DAGVPGHLCD GQWHKVTANK IKHRIELTVD GNQVEAQSPN PASTSADTND PVFVGGFPDD LKQFGLTTSI PFRGCIRSLK LTKGTGKPLE VNFAKALELR GVQPVSCPAN
    Kreuzreaktivität
    Human
    Produktmerkmale
    Antibody Reactive Against Recombinant Protein.
    Immunogen
    LAMA2 (NP_000417, 3013 a.a. ~ 3122 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
    Klon
    2D4
    Isotyp
    IgG1
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    In 1x PBS, pH 7.4
    Handhabung
    Aliquot to avoid repeated freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Zakrzewska, Fendler, Zakrzewski, Sikorska, Grajkowska, Dembowska-Bagińska, Filipek, Stefańczyk, Liberski: "Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma." in: PLoS ONE, Vol. 11, Issue 7, pp. e0158464, (2016) (PubMed).

    Araki, Chocholous, Gojo, Dorfer, Czech, Heinzl, Dieckmann, Ambros, Ambros, Slavc, Haberler: "Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma." in: Acta neuropathologica communications, Vol. 4, Issue 1, pp. 88, (2016) (PubMed).

    Dong, Ding, Young, Blaivas, Christensen, Wang: "Advanced intimal hyperplasia without luminal narrowing of leptomeningeal arteries in CADASIL." in: Stroke; a journal of cerebral circulation, Vol. 44, Issue 5, pp. 1456-8, (2013) (PubMed).

    Lemons, Feng, Bennett, Legesse-Miller, Johnson, Raitman, Pollina, Rabitz, Rabinowitz, Coller: "Quiescent fibroblasts exhibit high metabolic activity." in: PLoS biology, Vol. 8, Issue 10, pp. e1000514, (2010) (PubMed).

  • Target
    Laminin (LAMA2) (Laminin, alpha 2 (LAMA2))
    Andere Bezeichnung
    LAMA2 (LAMA2 Produkte)
    Synonyme
    LAMA2 antikoerper, LAMM antikoerper, 5830440B04 antikoerper, dy antikoerper, mKIAA4087 antikoerper, mer antikoerper, merosin antikoerper, laminin subunit alpha 2 antikoerper, laminin, alpha 2 antikoerper, laminin subunit alpha-2 antikoerper, LAMA2 antikoerper, lama2 antikoerper, LOC100460380 antikoerper, LOC100545053 antikoerper, Lama2 antikoerper
    Hintergrund
    Full Gene Name: laminin, alpha 2
    Synonyms: LAMM
    Gen-ID
    3908
    NCBI Accession
    NM_000426
Sie sind hier:
Kundenservice